Rethinking CRO Deposits: Russell's Alternative To Frozen Capital
Source: Clinical Leader
Instead of handing CROs a hefty security deposit — often $500K to $1M locked away for years — Russell Hayward negotiated milestone-based payments. He warns that traditional deposits tie up capital, can’t be expensed, and deliver no return, making them a major risk for small biotechs.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader